Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus (2012)
- Authors:
- USP affiliated authors: ROCHA, DALVA MARREIRO - FM ; PASQUALUCCI, SILVIA HELENA GELAS LAGE - FM ; WAJCHENBERG, BERNARDO LEO - FM ; FUKUI, ROSA TSUNECHIRO - FM
- Unidade: FM
- DOI: 10.6061/clinics/2012(07)03
- Subjects: FLUXO SANGUÍNEO; VASODILATAÇÃO; DIABETES MELLITUS NÃO INSULINO-DEPENDENTE; INSULINA (NÍVEL); DOENÇAS CARDIOVASCULARES (METABOLISMO;TERAPIA); ARTÉRIAS CARÓTIDA; HEMOSTASIA
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHADO, Helena Atroch et al. Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus. Clinics, v. 67, n. 7, p. 711-717, 2012Tradução . . Disponível em: https://doi.org/10.6061/clinics/2012(07)03. Acesso em: 23 fev. 2026. -
APA
Machado, H. A., Vieira, M., Cunha, M. R., Correia, M. R. S., Fukui, R. T., Santos, R. F. dos, et al. (2012). Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus. Clinics, 67( 7), 711-717. doi:10.6061/clinics/2012(07)03 -
NLM
Machado HA, Vieira M, Cunha MR, Correia MRS, Fukui RT, Santos RF dos, Rocha DM, Wajchenberg BL, Lage SHG, Silva MER da. Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus [Internet]. Clinics. 2012 ; 67( 7): 711-717.[citado 2026 fev. 23 ] Available from: https://doi.org/10.6061/clinics/2012(07)03 -
Vancouver
Machado HA, Vieira M, Cunha MR, Correia MRS, Fukui RT, Santos RF dos, Rocha DM, Wajchenberg BL, Lage SHG, Silva MER da. Metformin, but not glimepiride, improves carotid artery diameter and blood flow in patients with type 2 diabetes mellitus [Internet]. Clinics. 2012 ; 67( 7): 711-717.[citado 2026 fev. 23 ] Available from: https://doi.org/10.6061/clinics/2012(07)03 - Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients
- Differential regulation of PGC-1α expression in rat liver and skeletal muscle in response to voluntary running
- Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes
- Estrogênios conjugados equinos melhoram a complacência vascular em mulheres diabéticas menopausadas
- Efeitos metabólicos e na reatividade vascular de glimepiride e metformina em pacientes com diabetes tipo 2.
- Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
- Autoantibodies and High-Risk HLA Susceptibility Markers in First-Degree Relatives of Brazilian Patients with Type 1 Diabetes Mellitus: A Progression to Disease Based Study
- Analisys of the distribuition of class I and II VNTR alleles of the insulin gene linked minisatellite locus in type 1 diabetes mellitus in Brazil
- Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment
Informações sobre o DOI: 10.6061/clinics/2012(07)03 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
